Seth Rudnick, Director at G1 Therapeutics, Inc. (GTHX), sold 520 shares at $20.09 ($10K) on 2020-12-01, disclosed to the SEC on 2020-12-03.
Scheduled sale ($10k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GTHX | SELL | 2020-12-23 | $1.3M | — | Filing → |
| GTHX | SELL | 2020-12-10 | $777K | — | Filing → |
| GTHX | SELL | 2018-12-04 | $782K | — | Filing → |